- Report
- February 2022
- 75 Pages
Global
From €1900EUR$2,000USD£1,629GBP
- Drug Pipelines
- July 2020
- 131 Pages
Global
From €1900EUR$2,000USD£1,629GBP
- Report
- February 2024
- 108 Pages
Global
From €3500EUR$3,946USD£3,106GBP
- Report
- May 2023
- 233 Pages
Global
From €3392EUR$3,570USD£2,908GBP
- Report
- May 2023
- 160 Pages
Global
From €5699EUR$5,999USD£4,887GBP
The Fibromyalgia Drug market is a subset of the Immune Disorders Drugs market, which includes treatments for a variety of conditions related to the immune system. Fibromyalgia is a chronic disorder characterized by widespread musculoskeletal pain, fatigue, and tenderness in localized areas. Fibromyalgia drugs are used to reduce pain, improve sleep, and reduce fatigue. Commonly prescribed drugs include antidepressants, anticonvulsants, and muscle relaxants. Other treatments include physical therapy, cognitive behavioral therapy, and lifestyle modifications.
The Fibromyalgia Drug market is highly competitive, with a number of companies offering treatments. Some of the major players in the market include Pfizer, Eli Lilly, Merck, and Novartis. Other companies include AbbVie, Allergan, and Teva Pharmaceuticals. Show Less Read more